Aneurysmal bone cyst: results of an off label treatment with Denosumab

Aneurysmal bone cyst: results of an off label treatment with Denosumab

Abstract Background The treatment of aneurysmal bone cysts (ABCs) has evolved and less invasive methods have been tried. Denosumab is a monoclonal antibody which inhibits osteoclasts. It has been shown to be effective in giant cell tumour of bone (GCT) of bone and hence promises some effect also in...

Full description

Bibliographic Details
Main Authors: Hans Roland Dürr, Ferdinand Grahneis, Andrea Baur-Melnyk, Thomas Knösel, Christof Birkenmaier, Volkmar Jansson, Alexander Klein
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Musculoskeletal Disorders
Subjects:
Aneurysmal bone cyst
Denosumab
Recurrence
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12891-019-2855-y

Internet

http://link.springer.com/article/10.1186/s12891-019-2855-y

Similar Items